Proteolytic enzymes and their inhibitors in lung health and disease

Chronic Lung Disease in Early Infancy

Volumn , Issue , 1999, Pages 859-882

  Hoidal, John R ^a   Hoidal, Mari K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056974531     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (115)

1. Barrett AJ. Classification of peptidases. In: Barrett AJ, ed. Methods in Enzymology, Proteolytic Enzymes: Serine and Cysteine Peptides. San Diego: Academic Press, 1994.
2. Dalbey RE, von Heinje G. Signal peptidases in prokaryotes and eukaryotes—a new protease family? Trends Biol Sci 1992; 17:474.
3. Rechsteiner M, Hoffman L, Dubiel W. The multicatalytic and 26S proteases. J Biol Chem 1993; 268:6065.
4. Rawlings ND, Barrett AJ. Evolutionary families of peptides. Biochem J 1993; 290: 205.
5. Rawlings ND, Barrett AJ. Families of serine peptidases. In: Barrett AJ, ed. Methods in Enzymology, Proteolytic Enzymes: Serine and Cystein Peptidases. San Diego: Academic Press, 1994.
6. Henson PM, Johnston JRB. Tissue injury in inflammation: oxidants, proteinases and cationic proteins. J Clin Invest 1987; 79:669-674.
7. Janoff A. Elastase in tissue injury. Annu Rev Med 1985; 36:207-216.
8. Gabay JE. Antimicrobial proteins with homology to serine proteases. Ciba Found Symp 1994; 186:237-247.
9. Masson D, Tschopp J. A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 1987; 49:679-685.
10. Bleackley RC, Lobe CG, Duggan B, Ehrman N, Fregeau C, Mier M, Letellier M, Havele C, Shaw J, Paetkau V. The isolation and characterization of a family of serine protease genes in activated cytotoxic T lymphocytes. Immunol Rev 1988; 103:5-19.
11. Brian SD, Williams TJ. Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 1988; 335:73-75.
12. Sommerhoff CP, Caughey GH, Finkbeiner WE, Lazarus SC, Basbaum CB, Nadel JA. Mast cell chymase: a potent secretagogue for airway gland serous cells. J Immunol 1989; 142:2450-2456.
13. Caughey GH, Leidig F, Vino NF, Nadel JA. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 1988; 244:133-137.
14. Steiner DF, Smeekens SP, Ohagi S, Chan SJ. The new enzymology of precursor processing endoproteases. J Biol Chem 1992; 267:23435-23438.
15. Seidah NG, Chretien M, Day R. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie 1994; 76:197-209.
16. Twining SS. Regulation of proteolytic activity in tissues. Crit Rev Biochem Mol Biol 1994; 29:315-383.
17. Woessner JFJ. The family of matrix metalloproteinases. Ann NY Acad Sci 1994; 732:11-21.
18. Hibbs MS, Bainton DF. Human neutrophil gelatinase is a component of specific granules. J Clin Invest 1989; 84:1395.
19. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Structural and functional heterogeneity among peroxidase-negative granules in human neutrophils: identification of a distinct gelatinase-containing granule subset by combined immunocytochemis- try and subcellular fractionation. Blood 1993; 82:3183-3191.
20. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 1986; 261:6600-6605.
21. Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 1990; 265:11421-11424.
22. Freije JMP, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C. Molecular cloning and expression of collagenase-3, a novel human matrix metal- loproteinase produced by breast carcinomas. J Biol Chem 1994; 269:16766-16773.
23. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA, Goldberg GI. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988; 267:6579-6587.
24. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40- transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264:17213-17221.
25. Whitham SE, Murphy G, Angel P, Rahmsdorf HJ, Smith BJ, Lyons A, Harris TJ, Reynolds JJ, Herrlich P, Docherty AJ. Comparison of human stromelysin and colla- genase by cloning and sequence analysis. Biochem J 1986; 240:913-916.
26. Muller D, Quantin B, Gesnel MC, Millon-Collard R, Abecassis J, Breathnach R. The collagenase gene family in humans consists of at least four members. Biochem J 1988; 253:187-192.
27. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chen- ard MP, Rio MC, Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 348:699-704.
28. Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane- type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995; 260:23103-23020.
29. Lovejoy B, Cleasby A, Hassell AM, Inogley K, Luther MA, Wigl D, McGeehan G, McElroy AB, Drewry D, Lambert MH, Jordan SR. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 1994; 263: 375.
30. Rawlings ND, Barrett AJ. Families of cysteine peptidases. In: Barrett AJ, ed. Methods in Enzymology. Proteolytic enzymes: Serine and Cysteine Peptidases. San Diego: Academic Press, 1994.
31. Shinagawa T, Do YS, Baxter JK, Carilli C, Schilling J, Hsueh WA. Identification of an enzyme in human kidney that correctly processes prorenin. Proc Natl Acad Sci USA 1990; 87:1927-1933.
32. Kobayashi H, Schmitt M, Goretzki L, Chucholowski N, Calvete J, Kramer M, Gun- zaler WA, Janicke F, Graeff H. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase type plasminogen activator (pro-uPA). J Biol Chem 1991; 266:5147-5152.
33. Chapman HAJ, Munger JS, Shi G-P. The role of thiol proteases in tissue injury and remodeling. Am J Respir Crit Care Med 1994; 150:5155-5159.
34. Saido T, Sorimachi H, Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J 1994; 8:814.
35. Szecsi PB. The aspartic proteases. Scan J Clin Lab Invest 1992; 52:5-22.
36. Cavailles V, Augereau P, Rochefort H. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci USA 1993; 90:203.
37. Dikov MM, Springman EB, Yeola S, Serafin WE. Processing of procarboxypeptidase A and other zymogens in murine mast cells. J Biol Chem 1994; 269:25897-25904.
38. McGuire MJ, Lipsky PE, Thiele DL. Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J Biol Chem 1993; 268:2458-2467.
39. Komiyama T, Ray CA, Pickup DJ, Howard AD, Thornberry NA, Peterson EP. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem 1994; 269:19331-19337.
40. Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994; 269:15957-15960.
41. Huber R, Carrell RW. Implications of the three-dimensional structure of alpha 1- antitrypsin for structure and function of serpins. J Biochem 1989; 28:8951-8966.
42. Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequences of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986; 83:6692-6696.
43. Fritz H. Human mucus proteinase inhibitor (human MPI). Biol Chem Hoppe Seyler 1988; 369:79-82.
44. Boudier C, Bieth JG. The proteinase: mucus proteinase inhibitor binding stoichio- metery. J Biol Chem 1992; 267:4370-4375.
45. Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E. Elafin, an elas- tase-specific inhibitor from human skin. J Biol Chem 1990; 265:14791-14795.
46. Sallenave JM, Marsden MD, Ryle AP. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions: evidence of sequence homology and immunological cross-reactivity. Biol Chem Hoppe Seyler 1992; 373:27-33.
47. Salier JP. Inter-alpha-trypsin inhibitor: emergence of a family within the Kunitz- type protease inhibitor superfamily [review]. Trends Biochem Sci 1990; 15:435-439.
48. Potempa J, Kwon K, Chawla R, Travis J. Inter-alpha-trypsin inhibitor. Inhibition spectrum of native and derived forms. J Biol Chem 1989; 264:109.
49. Pratt CW, Roche PA, Pizzo SV. The role of inter-alpha-trypsin inhibitor and other proteinase inhibitors in the plasma clearance of neutrophil elastase and plasmin. Arch Biochem Biophys 1987; 258:591.
50. Willenbrock F, Murphy G. Structure-function relationships in the tissue inhibitors of metalloproteinases. Am J Respir Crit Care Med 1994; 150:S165-S170.
51. Turk V, Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991; 285:213-219.
52. Pontremoli S, Melloni E, Viotti PL, Michetti M, Salamino F, Horecker BL. Identification of two calpastatin forms in rat skeletal muscle and their susceptibility to digestion by homologous calpains. Arch Biochem Biophys 1991; 288:646-652.
53. Fusek M, Mares M, Vagner J, Voburka Z, Baudys M. Inhibition of aspartic protein- ases by propart peptides of human procathepsin D and chicken pepsinogen. FEBS Lett 1991; 287:160-162.
54. Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, Duncan IB, Galpin SA, Handa BK, Kay J, Krohn A. Rational design of peptide-based HIV proteinase inhibitors. Science 1990; 248:358-361.
55. Borth W. alpha 2-Macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 1992; 6:3345-3353.
56. Barrett AJ. Cellular proteolysis. An overview. Ann NY Acad Sci 1992; 674:1-15.
57. Altieri DC. Proteases and protease receptors in modulation of leukocyte effector functions. J Leukoc Biol 1995; 58:120-127.
58. Trinchieri G, DeMarchi M. Antibody-dependent cytotoxicity in humans. III. Effect of protease inhibitors and substrates. J Immunol 1972; 116:885-891.
59. Matter A. A study of proteolysis as a possible mechanism for T-cell mediated target cell lysis. Scand J Immunol 1975; 4:349-356.
60. Chang TW, Eisen HN. Effect of Na-tosyl-L-lysl-chloromethylketone on the activity of cytoxic T lymphocytes. J Immunol 1980; 124:1028-1033.
61. Shi L, Kam CM, Powers JC, Aebersold R, Greenberg AH. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 1992; 176:1521-1529.
62. Shiver JW, Su L, Henkart PA. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolsin and granzyme A. Cell 1992; 71: 315-322.
63. Heusel JW, Wesselschmidt RL, Shresta S, Russel JH, Ley TJ. Cytoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogenic target cells. Cell 1994; 76:977-987.
64. Trapani JA, Smyth MJ, Apostolidis VA, Dawson M, Browne KA. Granule serine proteases are normal nuclear constituents of natural killer cells. J Biol Chem 1994; 269:18359-18365.
65. Simon MM, Hoschutzky H, Furth V, Simon HG, Kramer MD. Purification and characterization of a T-cell specific serine protease (TSP-1) from clone cytolytic T lymphocytes. EMBO J 1986; 5:3267-3274.
66. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991; 88:493-499.
67. Chen LB, Teng NNH, Buchanan JM. Mitogenicity of thrombin and surface alterations on mouse splenocytes. Exp Cell Res 1976; 60:219-230.
68. Cohen SD, Israel E, Spiess-Meier B, Wainberg MA. Plasminogen activator is an apparent lymphocyte mitogen. J Immunol 1981; 126:1415-1420.
69. Arden MG, Adamson IY. Collagen degradation during postnatal lung growth in rats. Pediatr Pulmonol 1992; 14:95-101.
70. Minoo P, Penn R, deLemos DM, Coalson JJ, deLemos RA. Tissue inhibitor of metalloproteinase-1 mRNA is specifically induced in lung tissue after birth. Pediatr Res 1993; 34:729-734.
71. Gross NJ. Extracellular metabolism of pulmonary surfactant: the role of a new serine protease. Annu Rev Physiol 1995; 57:135-150.
72. Gross NJ, Schultz RM. Requirements for extracellular metabolism of pulmonary surfactant: tentative identification of serine protease. Am J Physiol 1992; 262: L446-L453.
73. Laurell CB, Eriksson S. The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15:132-140.
74. Janoff A, Sloan BGW, Damiano V, Sandhaus RA, Elias J, Kimbel P. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis 1977; 115:461-478.
75. Senior RM, Tegner H, Kuhn C, Ohlsson K, Starcher BC, Pierce JA. The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis 1977; 116:469-475.
76. Damiano VV, Tsang A, Kucich U, Abrams WR, Rosenbloom J, Kimbel P, Fallah- nejad M, Weinbaum G. Immunolocalization of elastase in human emphysematous lungs. J Clin Invest 1986; 78:482-493.
77. Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR. Proteinase 3: a distinct human polymorphonuclear leukocyte proteinase which produces emphysema in hamsters. J Clin Invest 1988; 82:1963-1973.
78. Shaprio SD. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. Am J Respir Crit Care Med 1994; 150:S160-S164.
79. Bruce MC, Ponca L, Klinger JC, Stern RC, Tomashefski JFJ, Dearborn DG. Biochemical and pathological evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 1985; 132:529-535.
80. Suter S, Schaad UB, Roux L, Nydegger UE, Waldvogel FA. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis 1984; 149:523-531.
81. Goldstein W, Doring G. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis 1986; 134:49-56.
82. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest 1990; 85:682-689.
83. Fick RB, Naegel GP, Squier SV, Wood RE, Bernard J, Gee L, Reynolds HY. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J Clin Invest 1984; 74:236-248.
84. Berger M, Sorensen RU, Tosi MR, Dearborn DG, Doring G. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest 1989; 84:1302-1313.
85. Power C, O’Connor CM, MacFarlane D, O’Mahoney S, Gaffney K, Hayes J, FitzGerald MX. Neutrophil collagenase in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 1994; 150:818-822.
86. Delacourt C, LeBourgeois M, D’Ortho MP, Doit C, Scheinmann P, Navarro J, Harf A, Hartmann DJ, Lafuma C. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 1995; 152:765-774.
87. Schwartz LB, Lewis RA, Austen KF. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem 1981; 256:1939-1943.
88. Rubinstein I, Nadel JA, Graf PD, Caughey GH. Mast cell chymase potentiates histamine-induced wheal formation in the skin of ragweed-allergic dogs. J Clin Invest 1990; 86:555-559.
89. Sage H, Bornstein RG, Bornstein P. Structural studies of human type IV collagen. J Biol Chem 1967; 254:9893-9900.
90. Seppa H, Vaananen D, Korhonen K. Effect of mast cell chymase of rat skin on intracellular matrix: a histochemical study. Acta Histochem (Jenna) 1979; 64:6470.
91. Briggaman RA, Schechter NM, Fraki J, Lazarus GS. Degradation of the epidermal- dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med 1984; 160:1027-1042.
92. Varsano S, Basbaum CB, Forsberg LS, Borson DB, Caughey GH, Nadel JA. Dog tracheal epithelial cells in culture synthesize sulfated macromolecular glycoconju- gates and release them from the cell surface upon exposure to extracellular protein- ases. Exp Lung Res 1987; 13:157-183.
93. Reilly DF, Schechter NB, Travis J. Inactivation of bradykinin and kallidin by ca- thepsin G and mast cell chymase. Biochem Biophys Res Commun 1985; 127:443-449.
94. Sekizawa K, Caughey GH, Lazarus SC, Gold WM, Nadel JA. Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. J Clin Invest 1989; 83: 175-179.
95. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95: 843-852.
96. Nakamura H, Yoshimura K, McElvaney NG, Crystal RG. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 1992; 89:1478-1484.
97. Matsunaga Y, Kido H, Kawaji K, Kamoshita K, Katunuma N, Ogura T. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils. Arch Biochem Biophys 1994; 312:67-74.
98. Lee CT, Fein AM, Lippmann M, Holtzman H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N Engl J Med 1981; 304:192-196.
99. Suter PM, Suter S, Girardin E, Roux-Lambard P, Grau GE, Dayer JM. High bron- choalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145:1016-1022.
100. Christner P, Fein A, Goldberg S, Lippmann M, Abrams W, Weinbaum G. Collage- nase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985; 131:690-695.
101. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis 1986; 133:218-225.
102. Gadek JE, Kelman JA, Fells G. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med 1979; 301:737-742.
103. Chanez P, Lacoste J, Guillot B, Giron J, Barneion G, Enhander I, Godard P, Michel FB, Bousqet J. Mast cells’ contribution to the fibrosing alveolitis of the scleroderma lung. Am Rev Respir Dis 1993; 147:1497-1502.
104. Hartmann T, Ruoss SJ, Raymond WW, Seuwen K, Caughey GH. Human tryptase as a potent, cell-specific mitogen: role of signaling pathways in synergistic responses. Am J Physiol 1992; 6:L528-L534.
105. Merritt TA, Chochrane CG, Holcomb K. Elastase and -proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 1983; 72:656-666.
106. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984; 130: 817-821.
107. Gerdes JS, Harris MC, Polin RA. Effects of dexamethasone and indomethacin on elastase, a1-proteinase inhibitor and fibronectin in bronchoalveolar lavage fluid from neonates. J Pediatr 1988; 113:727-731.
108. Walti H, Tordet C, Gerbaut L, Saugier P, Moriette G, Relier JP. Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections. Pediatr Res 1989; 26:351-355.
109. Gerdes JS, Whitsett J, Long W. Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant. J Pediatr 1992; 120:S34-S39.
110. Watterberg KL, Carmichael DF, Gerdes JS, Werner S, Backstro C, Murphy S. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia. J Pediatr 1994; 125:264-269.
111. Sluis KB, Darlow BA, Vissers MCM, Winterbourn CC. Proteinase-antiproteinase balance in tracheal aspirates from neonates. Eur Respir J 1994; 7:251-259.
112. Lyle RE, Tryka AF, Griffin WS, Taylor BJ. Tryptase immunoreactive mast cell hyperplasia in bronchopulmonary dysplasia. Pediatr Pulmonol 1995; 19:336-343.
113. Koppel R, Han RNH, Cox D, Tanswell AK. Antitrypsin protects neonatal rats from pulmonary vascular and parenchymal effects of oxygen toxicity. Pediatr Res 1995; 36:763-770.
114. Stiskal JA, Dunn MS, Shennan AT, O’Brien KKE, Kelly EN, Koppel RI, Cox DW, Ito S, Chappel SL, Rabinovitch M. a1-Proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: a randomized, controlled trial. Pediatrics 1998; 101:89-94.
115. Schmidt VA, Vitale E, Bahou WF. Genomic cloning and characterization of the human thrombin receptor gene. J Biol Chem 1996; 271:9307-9312.